Advertisement
Research Article| Volume 30, ISSUE 2, P116-120, July 15, 1991

Effect of electroconvulsive therapy on serum concentration of alpha-1-acid glycoprotein

  • C. Lindsay DeVane
    Correspondence
    Address reprint requests to Dr. C.L. DeVane, Box J-486, J. Hillis Miller Health Center, Gainesville, FL 32610-0436.
    Affiliations
    Department of Pharmacy Practice (CLD), University of Florida, Gainesville, FL, USA

    Department of Psychiatry (CLD, CL, DT, LH, MRW), University of Florida, Gainesville, FL, USA

    Division of Pharmacy Practice (SWC), University of North Carolina, and Princeton Pharmaceuticals, Inc., and Princeton Pharmaceuticals, Inc. (CL)., USA
    Search for articles by this author
  • Carolyn Lim
    Affiliations
    Department of Pharmacy Practice (CLD), University of Florida, Gainesville, FL, USA

    Department of Psychiatry (CLD, CL, DT, LH, MRW), University of Florida, Gainesville, FL, USA

    Division of Pharmacy Practice (SWC), University of North Carolina, and Princeton Pharmaceuticals, Inc., and Princeton Pharmaceuticals, Inc. (CL)., USA
    Search for articles by this author
  • Stanley W. Carson
    Affiliations
    Department of Pharmacy Practice (CLD), University of Florida, Gainesville, FL, USA

    Department of Psychiatry (CLD, CL, DT, LH, MRW), University of Florida, Gainesville, FL, USA

    Division of Pharmacy Practice (SWC), University of North Carolina, and Princeton Pharmaceuticals, Inc., and Princeton Pharmaceuticals, Inc. (CL)., USA
    Search for articles by this author
  • David Tingle
    Affiliations
    Department of Pharmacy Practice (CLD), University of Florida, Gainesville, FL, USA

    Department of Psychiatry (CLD, CL, DT, LH, MRW), University of Florida, Gainesville, FL, USA

    Division of Pharmacy Practice (SWC), University of North Carolina, and Princeton Pharmaceuticals, Inc., and Princeton Pharmaceuticals, Inc. (CL)., USA
    Search for articles by this author
  • Lynn Hackett
    Affiliations
    Department of Pharmacy Practice (CLD), University of Florida, Gainesville, FL, USA

    Department of Psychiatry (CLD, CL, DT, LH, MRW), University of Florida, Gainesville, FL, USA

    Division of Pharmacy Practice (SWC), University of North Carolina, and Princeton Pharmaceuticals, Inc., and Princeton Pharmaceuticals, Inc. (CL)., USA
    Search for articles by this author
  • Michael R. Ware
    Affiliations
    Department of Pharmacy Practice (CLD), University of Florida, Gainesville, FL, USA

    Department of Psychiatry (CLD, CL, DT, LH, MRW), University of Florida, Gainesville, FL, USA

    Division of Pharmacy Practice (SWC), University of North Carolina, and Princeton Pharmaceuticals, Inc., and Princeton Pharmaceuticals, Inc. (CL)., USA
    Search for articles by this author
DOI:https://doi.org/10.1016/0006-3223(91)90164-H
Effect of electroconvulsive therapy on serum concentration of alpha-1-acid glycoprotein
Previous ArticleSmoking and movement disorders in psychiatric patients
Next ArticlePlatelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Recent studies have shown significant alterations in serum alpha-1 acid glycoprotein (AGP) concentration in epileptic patients, the major protein to which basic drugs bind in serum. To date, there have been no reports in the literature investigating the effects of generalized seizures as a result of repeatedly administered electroconvulsive therapy (ECT) on this serum protein. As the cyclic antidepressants are basic drugs that bind avidly to AGP, an alterations of AGP concentration by ECT could represent a mechanism of interaction between two somatic treatments for depression. We therefore determined the serial AGP concentrations of 10 patients undergoing repeated ECT. AGP concentrations were determined by radial immunodiffusion on serum samples obtained at each treatment session (course of treatment ranged from 4 to 12 sessions over 8 to 32 days). The mean (SD) AGP concentrations prior to and at the end of ECT were 88.7 (18.3) mg/dl and 97.8 (24.8) mg/dl, respectively. Variability in AGP concentration was observed over the course of treatments with no consistent trend (intrapatient coefficients of variation averaged 11.5%). These data suggest that serial ECT does not produce consistent, significant changes in serum AGP concentrations and should have limited effects on altering the serum protein binding and, therefore, pharmacological effects of concurrently administered cyclic antidepressants.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Avery D.
        • Winokur G.
        The efficacy of electroconvulsive therapy and antidepressants in depression.
        Biol Psychiatry. 1977; 12: 507-523
        • Bauman P.
        • Tingwely D.
        • Schopf J.
        Increase of alpha-1-acid glycoprotein after treatment with amitriptyline.
        Br J Clin Pharmacol. 1982; 14: 102-103
        • Crowe R.R.
        Electroconvulsive therapy—A current perspective.
        New Engl J Med. 1984; 311: 163-166
        • Kornguth M.L.
        • Hutchins L.G.
        • Eichelman B.S.
        Binding of psychotropic drugs to isolated alpha-1-acid glycoprotein.
        Biochem Pharmacol. 1981; 30: 2435-2441
        • Nelson J.P.
        • Benjamin L.
        Efficacy and safety of combined ECT and tricyclic antidepressant drugs in the treatment of depressed geriatric patients.
        Convulsive Ther. 1989; 5: 321-329
        • Paxton J.W.
        Alpha-1-acid glycoprotein and binding of basic drugs.
        Methods Find Exp Clin Pharmacol. 1983; 5: 635-648
        • Piafsky K.M.
        • Borga O.
        Plasma protein binding of basic drugs. II. Importance of alpha-1-acid glycoprotein for interindividual variation.
        Clin Pharmacol Ther. 1977; 22: 545-549
        • Piafsky K.M.
        • Borga O.
        • Odar-Cederlof I.
        • Johansson C.
        • Sjoqvist F.
        Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha-1-acid glycoprotein.
        N Engl J Med. 1978; 299: 1435-1439
        • Wilkinson G.R.
        • Shand D.G.
        A physiological approach to hepatic drug clearance.
        Clin Pharmacol Ther. 1973; 18: 377-390
        • Yost R.L.
        • DeVane C.L.
        Diurnal variation of alpha-1-acid glycoprotein concentration in normal volunteers.
        J Pharm Sci. 1985; 74: 777-779

      Article info

      Publication history

      Received in revised form: December 20, 1990
      Received: June 22, 1990

      Identification

      DOI: https://doi.org/10.1016/0006-3223(91)90164-H

      Copyright

      © 1991 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX